ARCHIVES

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Upton Promises “Minimal Disruption” As Result of Changes; Centers Program Probably To Move

January 20, 1978

Board Commends M.D. Anderson On 50th Year

May 17, 1991

NCI Programs: Institute To Develop Plans For Large Trial Of Spiral CT Scanning For Lung Cancer

November 5, 1999

Drug Discovery Group Announcement Issued

January 7, 1983

Search Committee Sends Short List For NCI Director To HHS, White House

April 7, 1995

Crizotinib Eliminated Tumors In 7 of 8 Children with ALCL

May 25, 2012